| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
14.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$197.54 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
| Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
39 |
65 |
82 |
89 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Troendle August J. |
CEO |
• • • |
2021-12-10 |
4 |
AS |
$210.20 |
$64,952 |
I/I |
(309) |
5,758,230 |
|
-26% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-12-09 |
4 |
AS |
$212.13 |
$3,180,677 |
D/D |
(14,994) |
5,758,539 |
|
-26% |
|
| Troendle August J. |
CEO |
• • • |
2021-12-09 |
4 |
AS |
$212.13 |
$3,180,677 |
I/I |
(14,994) |
5,758,539 |
|
-26% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-12-08 |
4 |
AS |
$212.89 |
$3,378,777 |
D/D |
(15,871) |
5,773,533 |
|
-25% |
|
| Troendle August J. |
CEO |
• • • |
2021-12-08 |
4 |
AS |
$212.89 |
$3,378,777 |
I/I |
(15,871) |
5,773,533 |
|
-25% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-12-07 |
4 |
AS |
$211.78 |
$3,922,166 |
D/D |
(18,520) |
5,789,404 |
|
-27% |
|
| Troendle August J. |
CEO |
• • • |
2021-12-07 |
4 |
AS |
$211.78 |
$3,922,166 |
I/I |
(18,520) |
5,789,404 |
|
-27% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-12-03 |
4 |
AS |
$211.48 |
$84,592 |
D/D |
(400) |
5,807,924 |
|
-23% |
|
| Troendle August J. |
CEO |
• • • |
2021-12-03 |
4 |
AS |
$211.48 |
$84,592 |
I/I |
(400) |
5,807,924 |
|
-23% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-12-02 |
4 |
AS |
$210.79 |
$1,283,711 |
D/D |
(6,090) |
5,808,324 |
|
-23% |
|
| Troendle August J. |
CEO |
• • • |
2021-12-02 |
4 |
AS |
$210.79 |
$1,283,711 |
I/I |
(6,090) |
5,808,324 |
|
-23% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-12-01 |
4 |
AS |
$211.57 |
$5,636,648 |
D/D |
(26,642) |
5,814,414 |
|
-23% |
|
| Troendle August J. |
CEO |
• • • |
2021-12-01 |
4 |
AS |
$211.57 |
$5,636,648 |
I/I |
(26,642) |
5,814,414 |
|
-23% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-11-23 |
4 |
AS |
$212.64 |
$5,540,760 |
D/D |
(26,057) |
5,883,017 |
|
-24% |
|
| Troendle August J. |
CEO |
• • • |
2021-11-23 |
4 |
AS |
$212.64 |
$5,540,760 |
I/I |
(26,057) |
5,883,017 |
|
-24% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-11-22 |
4 |
AS |
$224.33 |
$10,796,554 |
D/D |
(48,128) |
5,909,074 |
|
-25% |
|
| Troendle August J. |
CEO |
• • • |
2021-11-22 |
4 |
AS |
$224.33 |
$10,796,554 |
I/I |
(48,128) |
5,909,074 |
|
-25% |
|
| King Tom C |
Director |
– • – |
2021-11-03 |
4 |
S |
$226.63 |
$39,887 |
D/D |
(176) |
598 |
|
27% |
|
| King Tom C |
Director |
– • – |
2021-11-03 |
4 |
OE |
$75.63 |
$37,815 |
D/D |
500 |
774 |
|
- |
|
| Brady Kevin M. |
CFO & Treasurer |
• – – |
2021-11-02 |
4 |
S |
$226.50 |
$283,125 |
D/D |
(1,250) |
5,000 |
|
32% |
|
| Brady Kevin M. |
CFO & Treasurer |
• – – |
2021-11-02 |
4 |
OE |
$90.65 |
$113,313 |
D/D |
1,250 |
6,250 |
|
- |
|
| Keating Ashley M. |
Director |
– • – |
2021-10-26 |
4 |
S |
$210.00 |
$420,000 |
D/D |
(2,000) |
0 |
|
29% |
|
| Keating Ashley M. |
Director |
– • – |
2021-10-26 |
4 |
OE |
$54.99 |
$109,980 |
D/D |
2,000 |
2,000 |
|
- |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2021-10-26 |
4 |
S |
$209.13 |
$2,091,300 |
D/D |
(10,000) |
13,854 |
|
29% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2021-10-26 |
4 |
OE |
$90.65 |
$906,500 |
D/D |
10,000 |
23,854 |
|
- |
|
215 Records found
|
|
Page 4 of 9 |
|
|
6.16 (1.58%) 
